SmallCap
CompaniesMapStatistics

티큐브잇 주식회사

Venture Certified
Data Quality: 7/10

Basic Information


Unlisted

Company Name티큐브잇 주식회사
Business Reg. No.1868801432
CEO김선택
Address세종특별자치시 조치원읍
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products세포치료제
EstablishedContact
Phone044-866-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.164711-*******

Investment Metrics


Market Cap
-
Op. Margin
-
ROE
-73.35%
Debt Ratio
94.08%

Certification Status


Venture Certified

Cert. History
기술평가대출기업(중진공)2020-04-20 ~ 2022-04-19202004007872020-04-20
벤처투자유형2022-04-20 ~ 2025-04-19202205040100172020-04-20
벤처투자유형2025-04-20 ~ 2028-04-19202503190100062020-04-20

Financial Statements


2-Year Financial Data
Item20232022
Revenue

0.0B

0.0B

Operating Profit

-20B

-12B

Net Profit

-19B

-12B

Total Assets

49B

50B

Total Liabilities

24B

5.8B

Total Equity

25B

44B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. Prior Year
Based on 2023
Revenue
0

- 0.0%

vs. Prior Year: 0
Operating Profit
-20B

67.8%

vs. Prior Year: -12B
Debt Ratio
94.1%

616.8%

vs. Prior Year: 13.1%
ROE
-73.4%

181.1%

vs. Prior Year: -26.1%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김선택대표이사대표

Employment Status


Regular EmployeesContact
CEO김선택

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "세종특별자치시 조치원읍",
  "ceo_name": "김선택",
  "certificate": [
    {
      "cert_number": "20200400787",
      "changes": "",
      "disclosure_date": "2020-04-20",
      "first_cert_date": "2020-04-20",
      "no": "1",
      "type": "기술평가대출기업(중진공)",
      "valid_period": "2020-04-20 ~ 2022-04-19"
    },
    {
      "cert_number": "20220504010017",
      "changes": "",
      "disclosure_date": "2022-05-04",
      "first_cert_date": "2020-04-20",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-04-20 ~ 2025-04-19"
    },
    {
      "cert_number": "20250319010006",
      "changes": "",
      "disclosure_date": "2025-03-19",
      "first_cert_date": "2020-04-20",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-04-20 ~ 2028-04-19"
    }
  ],
  "company_name": "티큐브잇 주식회사",
  "corp_no": "164711-*******",
  "financials": {
    "2022": {
      "capital_stock": 97263000,
      "cost_of_sales": 0,
      "current_assets": 4512362000,
      "current_liabilities": 477895000,
      "gross_profit": 0,
      "net_income": -1152612000,
      "net_income_bs": -1152612000,
      "non_current_assets": 484527000,
      "non_current_liabilities": 101890000,
      "non_operating_expenses": 5646000,
      "non_operating_income": 43092000,
      "operating_profit": -1190058000,
      "revenue": 0,
      "sga_expenses": 1190058000,
      "total_assets": 4996889000,
      "total_equity": 4417103000,
      "total_liabilities": 579786000
    },
    "2023": {
      "capital_stock": 97263000,
      "cost_of_sales": 0,
      "current_assets": 4084188000,
      "current_liabilities": 2328528000,
      "gross_profit": 0,
      "net_income": -1869062000,
      "net_income_bs": -1869062000,
      "non_current_assets": 861114000,
      "non_current_liabilities": 68738000,
      "non_operating_expenses": 31311000,
      "non_operating_income": 159058000,
      "operating_profit": -1996809000,
      "revenue": 0,
      "sga_expenses": 1996809000,
      "total_assets": 4945302000,
      "total_equity": 2548036000,
      "total_liabilities": 2397266000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,002,924,000",
      "changes": "1,002,924,000",
      "date": "2022-08-26"
    },
    {
      "amount": "1,002,924,000",
      "changes": "1,002,924,000",
      "date": "2022-08-26"
    },
    {
      "amount": "800,000,000",
      "changes": "800,000,000",
      "date": "2020-09-08"
    }
  ],
  "main_products": "세포치료제",
  "phone": "044-866-****",
  "years": [
    2023,
    2022
  ]
}

Data Sources


Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 6/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsNot Collected
Not Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected